The tumor environment such as fibrosis, hypoxia, dysregulated metabolism might also influence the liver cancer cell regulation of SCD and FADS2 enzyme activities especially in the case of HCC developed from NASH stage [81]. The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatohepatitis.